PRESS-RELEASE ·Filed Jul 16, 2026
Press release: earnings
Actionable Insight ▼ Bearish
The substantial EPS miss raises concerns about cost control and near-term profitability. Traders should watch the July 30 call for guidance updates and any commentary on pipeline progress or expense management.
Latest settled — T+20d ⚠ clustered
PTCT ▼ -8.34% at T+20d
SHORT call ✓ call won +8.34% · α vs SPY +11.96% · entry $78.52 → $71.97
Latest observation: T+52 +20.25% FF3 residual α
T+1d
+0.09%
call -0.09% · α -1.08%
$78.59
settled 3mo ago
T+5d
-0.09%
call +0.09% · α -1.58%
$78.45
settled 2mo ago
T+20d
-8.34%
call +8.34% · α +11.96%
$71.97
settled 7w ago
T+60d
—
call — · α —
—
in 7d
Price Chart
Loading chart...
Executive Summary
PTC Therapeutics reported Q2 2026 EPS of -$0.03, a 108% miss versus the $0.38 consensus, while revenue of $295.4M matched expectations. The large EPS miss, driven by higher operating costs, is a bearish signal ahead of the July 30 business update call.
Key Financial Metrics
EPS
$-0.03
est $0.38 · -107.9%
Revenue
$295.4M
est $295.4M · 0.0%
Rating
strong miss
Key Facts
- EPS of -$0.03 missed consensus of $0.38 by 108%
- Revenue of $295.4M was in line with consensus
- Company will host a Q2 2026 business update call on July 30
Financial Impact
EPS miss of $0.41 per share vs consensus
eps
Risk Factors
- Further earnings misses if cost pressures persist
- Pipeline setbacks or regulatory delays could compound negative sentiment
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302826736 |
15 reports for PTCT
100% Hit rate best @ T+60▲ +19.01%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | Insider Cluster | $69.82 $65.26 | ▼ −6.53% | ▼ −6.00% | $63.46 (−9.11%) |
Jul 16, 2026 11w ago | Press Release | $78.52 $71.97 | ▲ +8.34% | ▲ +11.96% | $63.46 (+19.18%) |
Jul 16, 2026 11w ago | Insider Cluster | $78.52 $71.97 | ▼ −8.34% | ▼ −11.96% | $63.46 (−19.18%) |
Jul 13, 2026 11w ago | Insider Cluster | $81.33 $74.63 | ▼ −8.24% | ▼ −11.42% | $63.46 (−21.97%) |
Jul 8, 2026 12w ago | Insider Cluster | $88.57 $69.21 | ▼ −21.86% | ▼ −25.13% | $63.46 (−28.35%) |
Jun 26, 2026 14w ago | Insider Cluster | $81.57 $76.82 | ▼ −5.82% | ▼ −5.54% | $63.46 (−22.20%) |
Jun 16, 2026 15w ago | 8-K | $73.27 $78.06 | ▲ +6.54% | ▲ +6.34% | $63.46 (−13.39%) |
Jun 9, 2026 16w ago | 8-K | $73.35 $89.55 | ▲ +22.09% | ▲ +18.46% | $63.46 (−13.48%) |
May 19, 2026 19w ago | Insider Cluster | $71.02 $78.98 | ▲ +11.21% | ▲ +10.47% | $63.46 (−10.64%) |
May 15, 2026 20w ago | Insider Cluster | $70.15 $73.27 | ▲ +4.45% | ▲ +2.87% | $63.46 (−9.54%) |
Showing 10 of 15
US Market Status
Market Closed — Opens Mon (64h 9m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access